To address the lack of information about clinical sequelae of coronavirus disease 2019 (COVID-19).
-
2021 (v1)PublicationUploaded on: February 14, 2024
-
2021 (v1)Publication
Low-dose dexamethasone reduces mortality in patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS). We retrospectively analyzed the efficacy of high-dose dexamethasone in patients with COVID-19-related ARDS and evaluated factors affecting the composite outcome (death or invasive mechanical...
Uploaded on: February 14, 2024 -
2022 (v1)Publication
Some patients affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) experience acute hypoxemic respiratory failure progressing toward atypical acute respiratory distress syndrome (ARDS). The aim of the study is to evaluate whether a correlation between ratio of peripheral saturation of oxygen (SpO2) and fraction of inspired...
Uploaded on: February 7, 2024